Tous Actualités
Suivre
Abonner Sanacorp Pharmahandel AG

Sanacorp Pharmahandel AG

euro adhoc: Sanacorp Pharmahandel AG
Justice/Processes
Sanacorp Pharmahandel AG reaches agreement on termination of avoidance action

  Disclosure announcement transmitted by euro adhoc. The issuer is responsible
  for the content of this announcement.
Spin-offs
22.10.2007
Sanacorp Pharmahandel AG and the shareholders who brought an action 
against Sanacorp Pharmahandel AG to set aside the resolutions passed 
at the Annual General Meeting held on June 27, 2007 (see ad hoc 
statement of August 21, 2007, 11:36:00 AM) have agreed today to end 
the dispute by way of a settlement in court.
The parties to the settlement - along with the four plaintiffs and 
Sanacorp Pharmahandel AG, this is also Sanacorp eG Pharmazeutische 
Großhandlung, which will join the action for the purpose of 
settlement - have agreed that a one-time special dividend of EUR 0.35
for each preference share be distributed in fiscal year 2008 to all 
preference shareholders of the defendant. This is to be a 
compensation for any disadvantages which the plaintiffs allege to 
suffer from the business combination of the pharmaceutical 
wholesaling companies Sanacorp Pharmahandel AG and Coopérative 
d´Exploitation et de Répartition Pharmaceutiques de Rouen S.A., 
Rouen, France (CERP Rouen). There will be no compensation to the sole
ordinary shareholder Sanacorp eG Pharmazeutischen Großhandlung.
For this purpose, Sanacorp eG Pharmazeutische Großhandlung undertakes
towards the plaintiffs and all other preference shareholders of 
Sanacorp Pharmahandel AG to agree on a change of the Articles of 
Incorporation on the occasion of the next annual general meeting of 
Sanacorp Pharmahandel AG, enabling the above-stated special dividend.
If the statutory requirements are met, i.e. if there is sufficient 
net retained profit in particular, the special dividend will be 
approved in the Annual General Meeting of Sanacorp Pharmahandel AG in
2009 and paid out then.
In addition, Sanacorp Pharmahandel AG has accepted the duty to keep 
the plaintiffs and the other preference shareholders informed.
The plaintiffs, in turn, will withdraw the action brought against 
Sanacorp Pharmahandel AG to set aside the resolutions passed at the 
Annual General Meeting held on June 27, 2007 in relation to the items
5, 7 and 8 of the agenda. Sanacorp Pharmahandel AG will bear the cost
of the litigation and the settlement.
To become effective, the settlement requires a declaration by the 
court. Details of the settlement, if it is reached upon the advice 
and request of the responsible court and if matching pleadings of all
parties involved are filed, will be published in the newspapers 
authorized to publish company announcements.
Planegg, October 22, 2007
Sanacorp Pharmahandel Aktiengesellschaft
The Management Board
end of announcement                               euro adhoc 22.10.2007 17:15:00

Further inquiry note:

Dr Thomas Strieder
Telefon: +49(089) 8581 494
E-Mail: ir@sanacorp.de

Branche: Wholesale
ISIN: DE0007163131
WKN: 716313
Index: CDAX, Classic All Share, Prime All Share
Börsen: Börse Frankfurt / official dealing/prime standard
Börse Berlin / free trade
Börse Hamburg / free trade
Börse Stuttgart / free trade
Börse Düsseldorf / free trade
Börse München / official dealing

Plus de actualités: Sanacorp Pharmahandel AG
Plus de actualités: Sanacorp Pharmahandel AG